Integrin modulators: a patent review

Abstract

Introduction: Integrins are heterodimeric cell surface receptors, which enable adhesion, proliferation, and migration of cells by recognizing binding motifs in extracellular matrix (ECM) proteins. As transmembrane linkers between the cytoskeleton and the ECM, they are able to recruit a huge variety of proteins and to influence signaling pathways bidirectionally, thereby regulating gene expression and cell survival. Hence, integrins play a key role in various physiological as well as pathological processes, which has turned them into an attractive target for pharmaceutical research.

Areas covered: In this review, the latest therapeutic developments of drug candidates and recently patented integrin ligands are summarized.

Expert opinion: Integrins have been proven to be valuable therapeutic targets in the treatment of several inflammatory and autoimmune diseases, where leukocyte adhesion processes are regulated by them. Furthermore, they play an important role in pathological angiogenesis and tumor metastasis, being a promising target for cancer therapy.

Keywords::

• angiogenesis
• cancer
• collagen-binding integrin receptor
• integrins
• laminin-binding integrin receptor
• leukocyte adhesion receptors

Notes

This box summarizes key points contained in the article.